使用刺猬信号通路抑制剂治疗晚期基底细胞癌：多学科专家会议
Treatment of Advanced Basal Cell Carcinoma with Hedgehog Pathway Inhibitors: A Multidisciplinary Expert Meeting.
作者信息
De Giorgi Vincenzo, Scarfì Federica, Trane Luciana, Silvestri Flavia, Venturi Federico, Zuccaro Biancamaria, Spinelli Giuseppe, Scoccianti Silvia, De Rosa Francesco, Dika Emi, Longo Caterina
机构信息
Section of Dermatology, Department of Health Sciences, University of Florence, 50100 Florence, Italy.
Cancer Research "AttiliaPofferi" Foundation, 50100 Pistoia, Italy.
出版信息
Cancers (Basel). 2021 Nov 15;13(22):5706. doi: 10.3390/cancers13225706.
Abstract
Despite recent progress and the publishing of several clinical guidelines on the management of advanced basal cell carcinoma, there is still no comprehensive set of clinical guidelines addressing the complexity inherent to the use of Hedgehog pathway inhibitors in the treatment of advanced basal cell carcinoma in real-world clinical practice. To develop practical and valuable tools that help specialists improve the clinical management of these patients, we sought the opinion of expert physicians with extensive knowledge and experience in the treatment of advanced basal cell carcinoma.
摘要
尽管最近取得了进展，并发布了几份关于晚期基底细胞癌管理的临床指南，但在现实世界的临床实践中，仍然没有一套全面的临床指南来应对在晚期基底细胞癌治疗中使用刺猬通路抑制剂所固有的复杂性。为了开发实用且有价值的工具，以帮助专家改善对这些患者的临床管理，我们征求了在晚期基底细胞癌治疗方面具有丰富知识和经验的专家医生的意见。
相似文献
1
Treatment of Advanced Basal Cell Carcinoma with Hedgehog Pathway Inhibitors: A Multidisciplinary Expert Meeting.使用刺猬信号通路抑制剂治疗晚期基底细胞癌：多学科专家会议
Cancers (Basel). 2021 Nov 15;13(22):5706. doi: 10.3390/cancers13225706.
2
Combined cemiplimab and radiotherapy for advanced basal cell carcinoma: A case report.西米普利单抗联合放疗治疗晚期基底细胞癌：一例报告
SAGE Open Med Case Rep. 2023 Mar 30;11:2050313X231164248. doi: 10.1177/2050313X231164248. eCollection 2023.
3
A Practical Guide for the Follow-Up of Patients with Advanced Basal Cell Carcinoma During Treatment with Hedgehog Pathway Inhibitors.晚期基底细胞癌患者接受 Hedgehog 通路抑制剂治疗时的随访实用指南。
Oncologist. 2019 Aug;24(8):e755-e764. doi: 10.1634/theoncologist.2018-0924. Epub 2019 May 9.
4
Sonidegib for the Treatment of Advanced Basal Cell Carcinoma.索尼德吉用于治疗晚期基底细胞癌。
Front Oncol. 2020 Oct 30;10:582866. doi: 10.3389/fonc.2020.582866. eCollection 2020.
5
Sonic Hedgehog Pathway Inhibition in the Treatment of Advanced Basal Cell Carcinoma.Sonic Hedgehog 通路抑制在晚期基底细胞癌治疗中的应用。
Curr Treat Options Oncol. 2019 Nov 26;20(11):84. doi: 10.1007/s11864-019-0683-9.
6
Characterization and Management of Hedgehog Pathway Inhibitor-Related Adverse Events in Patients With Advanced Basal Cell Carcinoma.晚期基底细胞癌患者中刺猬通路抑制剂相关不良事件的特征与管理
Oncologist. 2016 Oct;21(10):1218-1229. doi: 10.1634/theoncologist.2016-0186. Epub 2016 Aug 10.
7
High-Risk Recurrence Basal Cell Carcinoma: Focus on Hedgehog Pathway Inhibitors and Review of the Literature.高危复发性基底细胞癌：聚焦 Hedgehog 通路抑制剂及文献复习。
Chemotherapy. 2020;65(1-2):2-10. doi: 10.1159/000509156. Epub 2020 Aug 10.
8
Hedgehog Pathway Inhibition for the Treatment of Basal Cell Carcinoma. hedgehog 通路抑制治疗基底细胞癌。
Target Oncol. 2019 Jun;14(3):253-267. doi: 10.1007/s11523-019-00648-2.
9
The safety and efficacy of sonidegib for the treatment of locally advanced basal cell carcinoma.索尼德吉治疗局部晚期基底细胞癌的安全性和有效性。
Expert Rev Anticancer Ther. 2016 Oct;16(10):1011-8. doi: 10.1080/14737140.2016.1230020. Epub 2016 Sep 22.
10
Hedgehog Pathway Inhibitor Therapy for Locally Advanced and Metastatic Basal Cell Carcinoma: A Systematic Review and Pooled Analysis of Interventional Studies.Hedgehog 通路抑制剂治疗局部晚期和转移性基底细胞癌：干预性研究的系统评价和汇总分析。
JAMA Dermatol. 2016 Jul 1;152(7):816-24. doi: 10.1001/jamadermatol.2016.0780.
引用本文的文献
1
Palliative Radiotherapy to Preserve Eyesight in a Recurrent, Difficult-to-Treat Basal Cell Carcinoma.姑息性放疗用于保留复发性、难治疗的基底细胞癌患者的视力
Cureus. 2025 Jan 20;17(1):e77743. doi: 10.7759/cureus.77743. eCollection 2025 Jan.
2
Cutaneous Toxicities of Advanced Treatment for Cutaneous Melanoma: A Prospective Study from a Single-Center Institution.皮肤黑色素瘤晚期治疗的皮肤毒性：一项来自单中心机构的前瞻性研究。
Cancers (Basel). 2024 Oct 30;16(21):3679. doi: 10.3390/cancers16213679.
3
Basosquamous carcinoma: Comprehensive epidemiological, clinical, dermoscopic, and confocal features from a single center institution.基底鳞状细胞癌：来自单一中心机构的全面流行病学、临床、皮肤镜和共聚焦特征。
Skin Res Technol. 2024 Aug;30(8):e70012. doi: 10.1111/srt.70012.
4
Tolerance of sonidegib after intolerance of vismodegib-Experience in two patients with nevoid basal cell carcinoma syndrome (Gorlin syndrome).维莫德吉不耐受后索尼德吉的耐受性——两名痣样基底细胞癌综合征（戈林综合征）患者的经验
Skin Health Dis. 2023 Jun 14;3(5):e260. doi: 10.1002/ski2.260. eCollection 2023 Oct.
5
Experience with sonidegib in patients with advanced basal cell carcinoma: case reports.晚期基底细胞癌患者使用索尼德吉的经验：病例报告
Drugs Context. 2022 May 23;11. doi: 10.7573/dic.2022-3-8. eCollection 2022.
本文引用的文献
1
Ultraviolet Radiation and Basal Cell Carcinoma: An Environmental Perspective.紫外线辐射与基底细胞癌：环境视角。
Front Public Health. 2021 Jul 22;9:666528. doi: 10.3389/fpubh.2021.666528. eCollection 2021.
2
Lasting response after discontinuation of cemiplimab in a patient with locally advanced basal cell carcinoma.局部晚期基底细胞癌患者停用西米普利单抗后的持久反应。
Clin Exp Dermatol. 2021 Dec;46(8):1612-1614. doi: 10.1111/ced.14804. Epub 2021 Jul 29.
3
Cemiplimab in locally advanced basal cell carcinoma after hedgehog inhibitor therapy: an open-label, multi-centre, single-arm, phase 2 trial.西妥昔单抗治疗后局部晚期基底细胞癌：一项开放标签、多中心、单臂、2 期临床试验。
Lancet Oncol. 2021 Jun;22(6):848-857. doi: 10.1016/S1470-2045(21)00126-1. Epub 2021 May 14.
4
Vismodegib in neoadjuvant treatment of locally advanced basal cell carcinoma: First results of a multicenter, open-label, phase 2 trial (VISMONEO study): Neoadjuvant Vismodegib in Locally Advanced Basal Cell Carcinoma.维莫德吉用于局部晚期基底细胞癌的新辅助治疗：一项多中心、开放标签的2期试验（VISMONEO研究）的初步结果：维莫德吉用于局部晚期基底细胞癌的新辅助治疗
EClinicalMedicine. 2021 Apr 26;35:100844. doi: 10.1016/j.eclinm.2021.100844. eCollection 2021 May.
5
Vaccination against PD-L1 with IO103 a Novel Immune Modulatory Vaccine in Basal Cell Carcinoma: A Phase IIa Study.使用IO103（一种用于基底细胞癌的新型免疫调节疫苗）进行程序性死亡配体1（PD-L1）疫苗接种：一项IIa期研究。
Cancers (Basel). 2021 Feb 22;13(4):911. doi: 10.3390/cancers13040911.
6
A Review of Hedgehog Inhibitors Sonidegib and Vismodegib for Treatment of Advanced Basal Cell Carcinoma.《Hedgehog 抑制剂索立德吉和维莫德吉治疗晚期基底细胞癌的研究综述》。
J Drugs Dermatol. 2021 Feb 1;20(2):156-165. doi: 10.36849/JDD.5657.
7
Dose reduction during routine treatment of locally advanced basal cell carcinoma with the hedgehog inhibitor sonidegib to manage adverse effects: A retrospective case series.在使用刺猬信号通路抑制剂索尼德吉对局部晚期基底细胞癌进行常规治疗期间减少剂量以应对不良反应：一项回顾性病例系列研究。
J Am Acad Dermatol. 2021 Apr;84(4):e211-e212. doi: 10.1016/j.jaad.2020.12.006. Epub 2020 Dec 7.
8
Anti-PD-1 antibody therapy for epithelial skin malignancies: An investigator-initiated, open-label, single-arm, multicenter, phase II clinical trial (NMSC-PD1 Study).抗程序性死亡蛋白 1（PD-1）抗体治疗上皮性皮肤恶性肿瘤：一项研究者发起的、开放标签、单臂、多中心 II 期临床试验（非黑素瘤皮肤癌 - PD1 研究）
Medicine (Baltimore). 2020 Oct 30;99(44):e22913. doi: 10.1097/MD.0000000000022913.
9
Basal Cell Carcinoma: A Comprehensive Review.基底细胞癌：全面综述。
Int J Mol Sci. 2020 Aug 4;21(15):5572. doi: 10.3390/ijms21155572.
10
Immunologic Characteristics of Nonmelanoma Skin Cancers: Implications for Immunotherapy.非黑色素瘤皮肤癌的免疫特征：对免疫治疗的启示。
Am Soc Clin Oncol Educ Book. 2020 Mar;40:1-10. doi: 10.1200/EDBK_278953.
Zotero 插件